SCHEMBL27397491

SCHEMBL27397491

FC(F)(F)C(F)(C(F)(F)F)C1(C(F)(C(F)(F)F)C(F)(F)F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C1(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3209459 0.87 MEN1 (0.33)
SCHEMBL3151340 0.84 MEN1 (0.47)
SCHEMBL1066191 0.79
SCHEMBL10409113 0.78 MEN1 (0.40)
SCHEMBL1279347 0.76
SCHEMBL1279732 0.74
SCHEMBL3200848 0.71
SCHEMBL3226392 0.71
Perfluorocyclobutane SCHEMBL8841181 0.71 MEN1 (0.42)
SCHEMBL8841150 0.71 MEN1 (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1093283-A Be used to the compositions and the method that reduce toxicity and strengthen drug effect HEMAGEN PFC (US) 1994-10-12 CN disclosed